抗潰瘍薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3593)
◆英語タイトル:Global Antiulcerant Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3593
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、抗潰瘍薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(プロトンポンプ阻害剤、H2受容体拮抗薬、胃粘膜保護薬、抗生物質、制酸剤、プロスタグランジン作動薬)、用途別市場規模(口内潰瘍、胃潰瘍、下腿潰瘍、食道潰瘍、出血性潰瘍、神経障害性潰瘍、静脈うっ血性潰瘍、動脈性(虚血性)潰瘍、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・抗潰瘍薬の市場動向
・企業の競争状況、市場シェア
・抗潰瘍薬の種類別市場規模(プロトンポンプ阻害剤、H2受容体拮抗薬、胃粘膜保護薬、抗生物質、制酸剤、プロスタグランジン作動薬)
・抗潰瘍薬の用途別市場規模(口内潰瘍、胃潰瘍、下腿潰瘍、食道潰瘍、出血性潰瘍、神経障害性潰瘍、静脈うっ血性潰瘍、動脈性(虚血性)潰瘍、その他)
・抗潰瘍薬の北米市場規模2016-2027(アメリカ、カナダ)
・抗潰瘍薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・抗潰瘍薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・抗潰瘍薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・抗潰瘍薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Takeda Pharmaceutical、Eisai、Daewoong Pharmaceutical、Allergan、AstraZeneca plc、Valeant、Zydus、Shire)
・結論
【レポートの概要】

Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers.
Some of the popularAntiulcerant Drugs currently in use are H2 receptor antagonists, gastric mucosal protective drugs, antacids and antibiotics. They can also be used as proton pump inhibitors in combination therapy for patients at risk for gastrointestinal bleeding events. Their use prevents the generation of gastric acid in the stomach and lower abdomen. The increasing incidence of heartburn and indigestion caused by hyperacidity has helped Antiulcerant Drugs play an important role in treating gastric ulcers. Some Antiulcerant Drugs are also gaining popularity in the gastrointestinal irritation treatment.

Market Analysis and Insights: Global Antiulcerant Drugs Market
The global Antiulcerant Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiulcerant Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiulcerant Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiulcerant Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiulcerant Drugs market.

Global Antiulcerant Drugs Scope and Market Size
Antiulcerant Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiulcerant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists

Segment by Application
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Proton Pump Inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Gastric Mucosal Protective Drugs
1.2.5 Antibiotics
1.2.6 Antacids
1.2.7 Prostaglandin Agonists
1.3 Market by Application
1.3.1 Global Antiulcerant Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mouth Ulcers
1.3.3 Stomach Ulcers
1.3.4 Leg Ulcer
1.3.5 Esophageal Ulcer
1.3.6 Bleeding Ulcer
1.3.7 Neuropathic Ulcers
1.3.8 Venous Stasis Ulcers
1.3.9 Arterial (Ischemic) Ulcers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiulcerant Drugs Market Perspective (2016-2027)
2.2 Antiulcerant Drugs Growth Trends by Regions
2.2.1 Antiulcerant Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiulcerant Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Antiulcerant Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Antiulcerant Drugs Industry Dynamic
2.3.1 Antiulcerant Drugs Market Trends
2.3.2 Antiulcerant Drugs Market Drivers
2.3.3 Antiulcerant Drugs Market Challenges
2.3.4 Antiulcerant Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiulcerant Drugs Players by Revenue
3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2016-2021)
3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
3.4 Global Antiulcerant Drugs Market Concentration Ratio
3.4.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2020
3.5 Antiulcerant Drugs Key Players Head office and Area Served
3.6 Key Players Antiulcerant Drugs Product Solution and Service
3.7 Date of Enter into Antiulcerant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiulcerant Drugs Breakdown Data by Type
4.1 Global Antiulcerant Drugs Historic Market Size by Type (2016-2021)
4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2022-2027)

5 Antiulcerant Drugs Breakdown Data by Application
5.1 Global Antiulcerant Drugs Historic Market Size by Application (2016-2021)
5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antiulcerant Drugs Market Size (2016-2027)
6.2 North America Antiulcerant Drugs Market Size by Type
6.2.1 North America Antiulcerant Drugs Market Size by Type (2016-2021)
6.2.2 North America Antiulcerant Drugs Market Size by Type (2022-2027)
6.2.3 North America Antiulcerant Drugs Market Size by Type (2016-2027)
6.3 North America Antiulcerant Drugs Market Size by Application
6.3.1 North America Antiulcerant Drugs Market Size by Application (2016-2021)
6.3.2 North America Antiulcerant Drugs Market Size by Application (2022-2027)
6.3.3 North America Antiulcerant Drugs Market Size by Application (2016-2027)
6.4 North America Antiulcerant Drugs Market Size by Country
6.4.1 North America Antiulcerant Drugs Market Size by Country (2016-2021)
6.4.2 North America Antiulcerant Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antiulcerant Drugs Market Size (2016-2027)
7.2 Europe Antiulcerant Drugs Market Size by Type
7.2.1 Europe Antiulcerant Drugs Market Size by Type (2016-2021)
7.2.2 Europe Antiulcerant Drugs Market Size by Type (2022-2027)
7.2.3 Europe Antiulcerant Drugs Market Size by Type (2016-2027)
7.3 Europe Antiulcerant Drugs Market Size by Application
7.3.1 Europe Antiulcerant Drugs Market Size by Application (2016-2021)
7.3.2 Europe Antiulcerant Drugs Market Size by Application (2022-2027)
7.3.3 Europe Antiulcerant Drugs Market Size by Application (2016-2027)
7.4 Europe Antiulcerant Drugs Market Size by Country
7.4.1 Europe Antiulcerant Drugs Market Size by Country (2016-2021)
7.4.2 Europe Antiulcerant Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antiulcerant Drugs Market Size (2016-2027)
8.2 Asia-Pacific Antiulcerant Drugs Market Size by Type
8.2.1 Asia-Pacific Antiulcerant Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiulcerant Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiulcerant Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiulcerant Drugs Market Size by Application
8.3.1 Asia-Pacific Antiulcerant Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiulcerant Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiulcerant Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiulcerant Drugs Market Size by Region
8.4.1 Asia-Pacific Antiulcerant Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiulcerant Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antiulcerant Drugs Market Size (2016-2027)
9.2 Latin America Antiulcerant Drugs Market Size by Type
9.2.1 Latin America Antiulcerant Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Antiulcerant Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Antiulcerant Drugs Market Size by Type (2016-2027)
9.3 Latin America Antiulcerant Drugs Market Size by Application
9.3.1 Latin America Antiulcerant Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Antiulcerant Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Antiulcerant Drugs Market Size by Application (2016-2027)
9.4 Latin America Antiulcerant Drugs Market Size by Country
9.4.1 Latin America Antiulcerant Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Antiulcerant Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antiulcerant Drugs Market Size (2016-2027)
10.2 Middle East & Africa Antiulcerant Drugs Market Size by Type
10.2.1 Middle East & Africa Antiulcerant Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiulcerant Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiulcerant Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiulcerant Drugs Market Size by Application
10.3.1 Middle East & Africa Antiulcerant Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiulcerant Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiulcerant Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiulcerant Drugs Market Size by Country
10.4.1 Middle East & Africa Antiulcerant Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiulcerant Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Antiulcerant Drugs Introduction
11.2.4 Eisai Revenue in Antiulcerant Drugs Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Daewoong Pharmaceutical
11.3.1 Daewoong Pharmaceutical Company Details
11.3.2 Daewoong Pharmaceutical Business Overview
11.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
11.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021)
11.3.5 Daewoong Pharmaceutical Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Antiulcerant Drugs Introduction
11.4.4 Allergan Revenue in Antiulcerant Drugs Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Details
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
11.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2016-2021)
11.5.5 AstraZeneca plc Recent Development
11.6 Valeant
11.6.1 Valeant Company Details
11.6.2 Valeant Business Overview
11.6.3 Valeant Antiulcerant Drugs Introduction
11.6.4 Valeant Revenue in Antiulcerant Drugs Business (2016-2021)
11.6.5 Valeant Recent Development
11.7 Zydus
11.7.1 Zydus Company Details
11.7.2 Zydus Business Overview
11.7.3 Zydus Antiulcerant Drugs Introduction
11.7.4 Zydus Revenue in Antiulcerant Drugs Business (2016-2021)
11.7.5 Zydus Recent Development
11.8 Shire
11.8.1 Shire Company Details
11.8.2 Shire Business Overview
11.8.3 Shire Antiulcerant Drugs Introduction
11.8.4 Shire Revenue in Antiulcerant Drugs Business (2016-2021)
11.8.5 Shire Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗潰瘍薬の世界市場規模・現状・予測2021年-2027年(Global Antiulcerant Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。